Media relations
HOME>Company>Media relations
Taejoon Pharm. to Sponsor “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Service Aw
2017.01.24 | 김미희
The awards ceremony for “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Service Award” sponsored by Taejoon Pharm. (President Taeyoung Lee) was held through the 112th symposium of the Korean Ophthalmological Society at Exhibition Center 2, Ilsan KINTEX from Oct. 21 to Nov. 2.
Those honored with the awards include Prof. Seonggeun Jeong at Catholic University of Daegu School of Medicine (Taejoon Ophthalmology Service Award), Prof. Seokjung Jeong at Cha University School of Medicine (Taejoon Ophthalmology Best Thesis Award), Prof. Heungwon Cha at University of Ulsan College of Medicine (Taejoon Ophthalmology Excellent Award), and resident Yeongjin Lim at Gyeongsang University College of Medicine (Taejoon Ophthalmology Resident Award).
Taking this academic conference as an opportunity to publicize the excellence of their various ophthalmic products, Taejoon Pharm. set up promotion booths for introducing to the participants “New Hyalyuni Eye Drops 0.15% and New Hyal Drop 0.15%,” the first medications for dry eyes in Korea to contain 0.15% Sodium Hyaluronate; “Gatiflo,” a 4G antibiotic eye drop with low-level corneal toxicity; NSAID’s “Bronuck,” the No.1 next-generation prescription in USA; , “OCUAREDSTU M,” Korea’s first post-AREDS2 formula; “Xalost Eye Drops,” glaucoma medications exported to Europe; and other products.
During this academic conference period, Taejoon Pharm. held two symposiums for the participant ophthalmologists. On Nov. 1, as speakers, Prof. Shidong Kim at Catholic University of Daegu School of Medicine and Prof. Jaeryeong Oh at Korea University College of Medicine gave a presentation on “The Diagnosis and Management of Macular Degeneration. Are Eye Supplements Essential or Optional?” On the next day, Prof. Hyomyeong Kim at Korea University College of Medicine and Prof. Junyeong Han at Seoul National University College of Medicine gave a presentation on “The Effectiveness of a Combination of NSAIDs and Steroids Before and After Cataract Surgery” to receive a very positive response from the participants.
※Photo Description: First one from right Taeyoung Lee (President of Taejoon Pharm.), second one from right Prof. Seonggeun Jeong (Catholic University of Daegu School of Medicine), third one from right Yeonghun On (President of the Korea Ophthalmological Society) First one from right Taeyoung Lee (President of Taejoon Pharm.), second one from right resident Yeongjin Lim (Gyeongsang University College of Medicine), third one from right Heungwon Cha (University of Ulsan College of Medicine), fourth one from right Prof. Seokjung Jeong (Cha University School of Medicine), fifth one from right Mansu Kim (President of the Korea Ophthalmological Society)
The awards ceremony for “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Service Award” sponsored by Taejoon Pharm. (President Taeyoung Lee) was held through the 112th symposium of the Korean Ophthalmological Society at Exhibition Center 2, Ilsan KINTEX from Oct. 21 to Nov. 2.
Those honored with the awards include Prof. Seonggeun Jeong at Catholic University of Daegu School of Medicine (Taejoon Ophthalmology Service Award), Prof. Seokjung Jeong at Cha University School of Medicine (Taejoon Ophthalmology Best Thesis Award), Prof. Heungwon Cha at University of Ulsan College of Medicine (Taejoon Ophthalmology Excellent Award), and resident Yeongjin Lim at Gyeongsang University College of Medicine (Taejoon Ophthalmology Resident Award).
Taking this academic conference as an opportunity to publicize the excellence of their various ophthalmic products, Taejoon Pharm. set up promotion booths for introducing to the participants “New Hyalyuni Eye Drops 0.15% and New Hyal Drop 0.15%,” the first medications for dry eyes in Korea to contain 0.15% Sodium Hyaluronate; “Gatiflo,” a 4G antibiotic eye drop with low-level corneal toxicity; NSAID’s “Bronuck,” the No.1 next-generation prescription in USA; , “OCUAREDSTU M,” Korea’s first post-AREDS2 formula; “Xalost Eye Drops,” glaucoma medications exported to Europe; and other products.
During this academic conference period, Taejoon Pharm. held two symposiums for the participant ophthalmologists. On Nov. 1, as speakers, Prof. Shidong Kim at Catholic University of Daegu School of Medicine and Prof. Jaeryeong Oh at Korea University College of Medicine gave a presentation on “The Diagnosis and Management of Macular Degeneration. Are Eye Supplements Essential or Optional?” On the next day, Prof. Hyomyeong Kim at Korea University College of Medicine and Prof. Junyeong Han at Seoul National University College of Medicine gave a presentation on “The Effectiveness of a Combination of NSAIDs and Steroids Before and After Cataract Surgery” to receive a very positive response from the participants.
※Photo Description:
